There are 2934 resources available
1621 - Phase 1 Study of the Arginase Inhibitor INCB001158 (1158) Alone and in Combination with Pembrolizumab (PEM) in Patients (Pts) with Advanced/Metastatic (Adv/Met) Solid Tumors
Presenter: Aung Naing
Session: Proffered Paper – Developmental therapeutics
Resources:
Abstract
Slides
Webcast
441O - A Platform Trial with a Registry Study for Rare Cancers: MASTER KEY Project
Presenter: Shoko Narita
Session: Proffered Paper – Developmental therapeutics
Resources:
Abstract
Slides
Webcast
2651 - Therapeutic drug monitoring of oral anticancer drugs - preliminary results of a prospective study
Presenter: Steffie Groenland
Session: Proffered Paper – Developmental therapeutics
Resources:
Abstract
Slides
Webcast
3410 - METEOR-1: A Phase I Study of GSK3326595, a First-In-Class Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Advanced Solid Tumors
Presenter: Lillian Siu
Session: Proffered Paper – Developmental therapeutics
Resources:
Abstract
Slides
Webcast
3974 - 177Lu-DOTATATE plus 166Ho-radioembolization in patients with neuroendocrine tumours; a single center, prospective, interventional, non-comparative, open label, phase II study (HEPAR PLUS study)
Presenter: Sander Ebbers
Session: Proffered Paper – NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
2442 - RNA expression profiles and splicing alterations in grade 1/2 neuroendocrine neoplasms from small intestine origin (siNENs). Final results of the GETNE-NETSEQ study
Presenter: Jaume Capdevila
Session: Proffered Paper – NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1796 - Malignant Non-adrenal Paraganglioma (mPara) and Adrenal Pheochromocytoma (mPheo) a Comparative Comprehensive Genomic Profiling (CGP) Study
Presenter: Gennady Bratslavsky
Session: Proffered Paper – NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
4979 - Efficacy and safety of surufatinib in patients with well-differentiated advanced extrapancreatic neuroendocrine tumors (NETs): results from the randomized phase III study (SANET-ep)
Presenter: Jianming Xu
Session: Proffered Paper – NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
2402 - Registrational Results of LOXO-292 in Patients with RET-Altered Thyroid Cancers
Presenter: Lori Wirth
Session: Proffered Paper – NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
4134 - Pembrolizumab (pembro) + chemotherapy (chemo) in metastatic squamous NSCLC: final analysis and progression after the next line of therapy (PFS2) in KEYNOTE-407
Presenter: Luis Paz-Ares
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract
Slides